Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NRICM102
- Development stage
- Phase 2
- Lead developer
- National Research Institute of Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
NRICM102 is a multi-herbal traditional Chinese medicine (TCM) formulation developed by the National Research Institute of Chinese Medicine (NRICM) in Taiwan. Originally designed as a therapeutic for COVID-19, it has been investigated for its potential in treating chronic obstructive pulmonary disease (COPD) and other inflammatory lung injuries. The formula acts as an immunomodulator and anti-inflammatory agent, demonstrating the ability to improve pulmonary function, preserve lung architecture, and reduce the expression of key inflammatory markers including IL-1β, NLRP3, Muc5ac, and MMP12. It works by selectively modulating immune-related pathways, reversing COPD-associated gene expression patterns, and reducing cytokine signaling and chemokine activity.
- Other names
- Qingguan No. 2
02
Targets
IL1B (Interleukin-1 beta)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)MMP12 (Macrophage Metalloelastase)MUC5AC (Mucin-5AC)
Beyond the preview
Go deeper on NRICM102.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NRICM102.